Medulloblastoma is one of the leading causes of morbidity and mortality in pediatric cancer. Wnt-active tumors, an independent molecular subgroup in medulloblastoma, are characterized by a distinct pattern of genomic aberrations. We assessed the anticancer activity of cantharidin and norcantharidin against medulloblastoma, as cell lines in vitro and in athymic nude mice in vivo. Cantharidin and norcantharidin treatment impaired the growth of DAOY and UW228 medulloblastoma cells and promoted the loss of β-catenin activation and the β-catenin nuclearization linked to N-cadherin impairment in vitro. Intra-peritoneal administration of norcantharidin inhibited the growth of intra-cerebellum tumors in orthotopic xenograft nude mice. Analysis of the xenograft tissues revealed enhanced neuronal differentiation and reduced β-catenin expression. Our findings suggest that norcantharidin has potential therapeutic applications in the treatment of medulloblastoma as a result of its ability to cross the blood-brain barrier and its impairment of Wnt-β-catenin signaling.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1007/s11060-011-0645-y | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
The emerging role of FAM46C as a biomarker and therapeutic target in gastric adenocarcinoma.
J Gastrointest Oncol
August 2024
Department of Surgery, University of Toronto, Toronto, Canada.
Article Synopsis
- Gastric adenocarcinoma (GCa) has a high fatality rate in Europe and North America, largely due to late-stage diagnoses, despite advancements in treatment options.
- There is significant interest in FAM46C, a protein linked to tumor suppression, as its depletion is commonly observed in GCa patients and is associated with cancer recurrence and mortality.
- Research is exploring FAM46C as a potential biomarker and therapeutic target for GCa progression, with Norcantharidin emerging as a promising compound to restore FAM46C levels currently in phase one clinical trials.
Norcantharidin Enhances the Antitumor Effect of 5-Fluorouracil by Inducing Apoptosis of Cervical Cancer Cells: Network Pharmacology, Molecular Docking, and Experimental Validation.
Curr Issues Mol Biol
April 2024
GuiZhou University Medical College, Guiyang 550025, China.
Article Synopsis
- Cervical cancer is a serious disease that affects many women and can be deadly.
- Researchers studied the effects of a cancer drug called Norcantharidin (NCTD) when used with another drug called 5-Fluorouracil (5-FU) to see if they could work better together to kill cervical cancer cells.
- Their tests showed that NCTD makes 5-FU more effective by helping the cancer cells die and activating specific proteins that cause this process.
Norcantharidin Sensitizes Colorectal Cancer Cells to Radiotherapy via Reactive Oxygen Species-DRP1-Mediated Mitochondrial Damage.
Antioxidants (Basel)
March 2024
Department of Oncology, Tianjin Union Medical Center, Nankai University, Tianjin 300350, China.
Norcantharidin (NCTD), a cantharidin derivative, induces ROS generation and is widely used to treat CRC. In this study, we clarified the role and mechanism of action of norcantharidin in increasing CRC sensitivity to radiotherapy. We treated the CRC cell lines LoVo and DLD-1 with NCTD (10 or 50 μmol/L), ionizing radiation (IR, 6 Gy), and a combination of the two and found that NCTD significantly inhibited the proliferation of CRC cells and enhanced their sensitivity to radiotherapy.
View Article and Find Full Text PDFMechanisms of norcantharidin against renal tubulointerstitial fibrosis.
Pharmacol Rep
April 2024
Institute of Geriatrics (Shanghai University), Affiliated Nantong Hospital of Shanghai University (The Sixth People's Hospital of Nantong), School of Medicine, Shanghai University, 881 Yonghe Road, Nantong, 226001 , Jiangsu, China.
Renal tubulointerstitial fibrosis (RTIF) is a common feature and inevitable consequence of all progressive chronic kidney diseases, leading to end-stage renal failure regardless of the initial cause. Although research over the past few decades has greatly improved our understanding of the pathophysiology of RTIF, until now there has been no specific treatment available that can halt the progression of RTIF. Norcantharidin (NCTD) is a demethylated analogue of cantharidin, a natural compound isolated from 1500 species of medicinal insect, the blister beetle (Mylabris phalerata Pallas), traditionally used for medicinal purposes.
View Article and Find Full Text PDFNorcantharidin in cancer therapy - a new approach to overcoming therapeutic resistance: A review.
Medicine (Baltimore)
March 2024
Department of Oncology, Affiliated Hospital of North Sichuan Medical College, Nanchong, Sichuan, China.
Therapeutic resistance in cancer remains a dilemma that scientists and oncologists are eager to solve. Despite several preclinical and clinical studies dedicated to overcoming therapeutic resistance, they often do not yield the expected outcomes. This is primarily due to the multifactorial phenomenon of therapeutic resistance.
View Article and Find Full Text PDFWant AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!